Top U.S. health officials believe that Pfizer Inc's (PFE.N) COVID-19 vaccine could be authorized for children aged 5-11 years old by the end of October, two sources familiar with the situation said on Friday.https://t.co/hTYIceUtQ7

— Jonathan Landay (@JonathanLanday) September 10, 2021